Explore the emerging opportunities for medical device companies in China?" Find out why some analysts are predicting a compound annual growth rate of 15% over the next 10 years from a base of approximately $10 billion in 2007.
Continue reading "China: The Wild, Wild East for Medical Devices" »
This exclusive interview is reprinted from PharmAsia News - May 27, 2008
Find out how one Australia-based company is making the most of the niche market opportunities in the specialty medical technology markets of China and North Asia in our exclusive interview with Helicon's CEO Peter Abrahamson.
Reprinted from PharmAsia News, May 19, 2008
Paragon Medical, a leading U.S. original equipment manufacturer for the top global medical device suppliers, has selected Changzhou High-tech District as its strategic location to invest in China. As a key export production base for Asia Pacific, the Changzhou facility will mainly manufacture class I orthopedic devices, class I implant components and other metal medical devices. Most of the products will be distributed to the overseas market. (Click here for more - Chinese Language)
"American Paragon Medical Sets Up Export Production Base In Changzhou" - hc360.com (5/13/08)
Click here for a 30-day free trial of PharmAsia News: Drugs - Biologics - Devices
Reprinted from PharmAsia News, May 19, 2008
India's Agappe Diagnostics says it expects a 300 percent growth over the rest of this year, three times the percentage growth of the previous year. Agappe attributed the expected gains to an appreciating euro and high prices in Western countries. Agappe's managing director, Thomas John, said his firm expects to acquire technology to help it take advantage of India's lower manufacturing costs. John said the past year's situation of an appreciating euro and high Western production costs caused problems in reducing prices, but the technology aspect was expected to be an offset. (Click here for more)
"Agappe Diagnostics Eyeing 300 Percent Growth" - Economic Times (India) (5/17/08)
